Gilead Sciences to Present at Upcoming Investor Conferences
Get Alerts GILD Hot Sheet
Join SI Premium – FREE
FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conferences:
Wells Fargo Healthcare Conference Wednesday, September 6 at 11:00 am ET
Morgan Stanley Annual Global Healthcare Conference on Tuesday, September 12 at 11:30 am ET
The live webcasts can be accessed at the company’s investors page at investors.gilead.com. The replays will be available for at least 30 days following the presentation.
About Gilead Sciences
Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.
For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230823013787/en/
Jacquie Ross, CFA – Investors
[email protected]
Source: Gilead Sciences, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU approves Gilead's Trodelvy combo with Keytruda for front-line TNBC
- Natural Grocers® Announces One-Day Anniversary Afterparty With Encore Savings, Freebies and a Chance to Win a Year of Free Groceries, Aug. 27, 2026
- Best Meme Coins to Watch: Apeing’s Whitelist Emerges as a Wildcard with Top 11 Coins
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
Morgan Stanley, Twitter, Wells FargoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share